v3.26.1
Condensed Statements of Operations (Unaudited) - USD ($)
3 Months Ended 6 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Mar. 31, 2026
Mar. 31, 2025
Income Statement [Abstract]        
Product revenue $ 1,862,050 $ 1,386,550 $ 4,754,685 $ 4,660,717
Cost of product revenue 871,786 615,489 2,196,593 1,962,767
Product gross profit 990,264 771,061 2,558,092 2,697,950
License revenue 3,000,000
Operating expenses:        
Selling, general and administrative 1,919,371 1,940,414 3,804,826 3,983,868
Research and development 1,468,090 1,510,663 2,857,770 2,682,891
Total operating expenses 3,387,461 3,451,077 6,662,596 6,666,759
Loss from operations (2,397,197) (2,680,016) (4,104,504) (968,809)
Fair value change in warrant liability (8,271) 390,351 214,469 779,796
Financing costs (324,738)
Other income 23,446 19,058 70,123 28,466
Loss before income taxes (2,382,022) (2,270,607) (3,819,912) (485,285)
Provision for income taxes
Net loss $ (2,382,022) $ (2,270,607) $ (3,819,912) $ (485,285)
Net loss per share (Note 1):        
Basic (in Dollars per share) $ (0.28) $ (0.44) $ (0.45) $ (0.09)
Diluted (in Dollars per share) [1] $ (0.28) $ (0.44) $ (0.47) $ (0.09)
Number of shares used in per share calculations (Note 1):        
Basic (in Shares) 8,484,926 5,185,075 8,436,158 5,161,971
Diluted (in Shares) [1] 8,484,926 5,185,075 8,554,213 5,161,971
[1] For the three and six months ended March 31, 2025, no adjustment was made to the numerator and no incremental shares were added to the denominator for the PIPE Warrants being accounted for as a derivative liability as the PIPE Warrants were out-of-the-money during these periods. See “Note 13 - Stockholders’ Equity”.